<DOC>
	<DOC>NCT00097708</DOC>
	<brief_summary>The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.</brief_summary>
	<brief_title>Experimental Medication For the Treatment of Generalized Anxiety Disorder</brief_title>
	<detailed_description>Protocol 04-001-01 The primary objective of the study is to assess, under controlled conditions, the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder (GAD). The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication. Recruiting: Participants are currently being recruited and enrolled.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Anti-Anxiety Agents</mesh_term>
	<criteria>Subjects 18 to 65 years of age will be eligible to participate if they satisfy the DSMIVTR criteria for the diagnosis of GAD. No other primary psychiatric diagnosis besides GAD.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Double Blind, Placebo controlled, Safety and Efficacy</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
</DOC>